Cell Culture Market, by Equipment [Bioreactor, Culture Vessels (Multiwell Plates, Petri Dish)], Consumables (FBS, ABS, Media, Reagents), Application (Therapeutic, Stem Cell), End Users (Pharmaceutical and Biotechnology, Research)Growing Awareness on the Benefits of Cell-Culture Based Vaccines: A Major Driver for Market Growth
The cell culture market is projected to reach USD 18,630.7 million by 2020 from USD 11,310.9 million in 2015, at a CAGR of 10.5%. This market is categorized on the basis of products, applications, end users, and regions.
Get Sample Copy for more professional insights Here@ www.reportsnreports.com/contacts/r….aspx?name=291293
Major factors contributing to the growth of the global cell culture market include the increasing incidence of chronic diseases, growth in number of regulatory approvals for cell culture-based vaccines, growing demand for mAbs, funding for cell-based research, rising adoption of single-use technologies, and technological advancements in cell culture products. However, factors such as high cost of research in cell biology and lack of infrastructure for cell-based research are likely to hinder the growth of this market during the forecast period.
The cell culture market in Asia is expected to witness the highest growth rate from 2015-2020. Emerging economies such as China and India preferred destinations for major pharmaceutical giants as the cost of production is significantly lower compared to developed nations.
Moreover, regulatory norms in these countries are less stringent and the cost of labor is less. This in turn reduces the cost of production of biologics.
Owing to these benefits, various pharmaceutical giants are actively investing in these markets to develop biopharmaceutical drugs. For instance, in June 2013, Boehringer Ingelheim (Germany) invested €35 million (USD 46.4 million) to establish a cGMP biopharmaceutical manufacturing facility in China.
Report on Cell culture Market 2017-2020 spreads across 264 pages profiling 10 companies and supported with 232 tables and 57 figures available at www.reportsnreports.com/contacts/d….aspx?name=291293
*Top 10 Companies Analysed for This Study are
(Overview, Financials, Products & Services, Strategy, & Developments)*- Thermo Fisher Scientific, Inc., Merck KGAA, GE Healthcare (A Subsidiary of General Electric Company), Lonza Group AG, Corning, Inc, Becton, Dickinson and Company, Eppendorf AG, Hi-Media Laboratories, Sartorius AG, Promocell GmbH.*Details on Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.
Apart from the comprehensive regional analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. The company profiles comprise basic views on key players and their product portfolios, developments, and strategies adopted.
The abovementioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, change in strategic approach, R&D investments, and levels of output in order to remain successful.
Key point from table of content
6 Cell Culture Market, By Product
18.104.22.168 Conventional Bioreactors
22.214.171.124 Single-Use Bioreactors
7 Cell Culture Market, By Application
7.1 Biopharmaceutical/Therapeutic Applications
7.1.1 Vaccine Production
8 Cell Culture Market, By End User
8.2 Pharmaceutical and Biotechnology Companies
Browse Here for full Report with TOC: www.reportsnreports.com/reports/51…sts-to-2020.html